INS and type 2 diabetes mellitus: Scores similar to 31.3% in an Algerian study on type 2 diabetics (on ADO and/or insulin) [12], 33.1% in an Ethiopian study of a similar size population [18], but lower than 88.1% in a Pakistani study of type 1 diabetics on insulin [19] were published.